1. Home
  2. USAS vs PVLA Comparison

USAS vs PVLA Comparison

Compare USAS & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$4.56

Market Cap

1.5B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$129.84

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
PVLA
Founded
1998
2015
Country
Canada
United States
Employees
N/A
29
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
USAS
PVLA
Price
$4.56
$129.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
15
Target Price
$6.50
$171.87
AVG Volume (30 Days)
4.1M
237.1K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.68
N/A
Revenue Next Year
$53.17
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$21.55
52 Week High
$10.50
$151.18

Technical Indicators

Market Signals
Indicator
USAS
PVLA
Relative Strength Index (RSI) 35.69 61.94
Support Level $3.53 $109.68
Resistance Level $5.12 $135.23
Average True Range (ATR) 0.38 6.89
MACD -0.05 2.16
Stochastic Oscillator 3.10 96.63

Price Performance

Historical Comparison
USAS
PVLA

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: